Skip to main content
Top
Published in: Journal of Translational Medicine 1/2009

Open Access 01-12-2009 | Research

Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells

Authors: Paola Bontempo, Luigi Mita, Antonella Doto, Marco Miceli, Angela Nebbioso, Ilaria Lepore, GianLuigi Franci, Roberta Menafra, Vincenzo Carafa, Mariarosaria Conte, Floriana De Bellis, Fabio Manzo, Vincenzo Di Cerbo, Rosaria Benedetti, Loredana D'Amato, Maria Marino, Alessandro Bolli, Giovanna Del Pozzo, Nadia Diano, Marianna Portaccio, Gustavo D Mita, Maria Teresa Vietri, Michele Cioffi, Ernesto Nola, Carmela Dell'Aversana, Vincenzo Sica, Anna Maria Molinari, Lucia Altucci

Published in: Journal of Translational Medicine | Issue 1/2009

Login to get access

Abstract

Background:

BPA (bisphenol A or 2,2-bis(4-hydroxy-phenol)propane) is present in the manufacture of polycarbonate plastic and epoxy resins, which can be used in impact-resistant safety equipment and baby bottles, as protective coatings inside metal food containers, and as composites and sealants in dentistry. Recently, attention has focused on the estrogen-like and carcinogenic adverse effects of BPA. Thus, it is necessary to investigate the cytotoxicity and apoptosis-inducing activity of this compound.

Methods:

Cell cycle, apoptosis and differentiation analyses; western blots.

Results:

BPA is able to induce cell cycle arrest and apoptosis in three different acute myeloid leukemias. Although some granulocytic differentiation concomitantly occurred in NB4 cells upon BPA treatment, the major action was the induction of apoptosis. BPA mediated apoptosis was caspase dependent and occurred by activation of extrinsic and intrinsic cell death pathways modulating both FAS and TRAIL and by inducing BAD phosphorylation in NB4 cells. Finally, also non genomic actions such as the early decrease of both ERK and AKT phosphorylation were induced by BPA thus indicating that a complex intersection of regulations occur for the apoptotic action of BPA.

Conclusion:

BPA is able to induce apoptosis in leukemia cells via caspase activation and involvement of both intrinsic and extrinsic pathways of apoptosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Colborn T, vom Saal FS, Soto AM: Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect. 1993, 101: 378-384. 10.2307/3431890.PubMedCentralCrossRefPubMed Colborn T, vom Saal FS, Soto AM: Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect. 1993, 101: 378-384. 10.2307/3431890.PubMedCentralCrossRefPubMed
2.
go back to reference Vandelac L: Endocrine disruption agents: environment, health, public policies, and the precautionary principle. Bull Acad Natl Med. 2000, 184: 1477-1486. discussion 1487–1490PubMed Vandelac L: Endocrine disruption agents: environment, health, public policies, and the precautionary principle. Bull Acad Natl Med. 2000, 184: 1477-1486. discussion 1487–1490PubMed
3.
go back to reference Vasseur P, Cossu-Leguille C: Linking molecular interactions to consequent effects of persistent organic pollutants (POPs) upon populations. Chemosphere. 2006, 62: 1033-1042. 10.1016/j.chemosphere.2005.05.043.CrossRefPubMed Vasseur P, Cossu-Leguille C: Linking molecular interactions to consequent effects of persistent organic pollutants (POPs) upon populations. Chemosphere. 2006, 62: 1033-1042. 10.1016/j.chemosphere.2005.05.043.CrossRefPubMed
4.
go back to reference Cheek AO, Kow K, Chen J, McLachlan JA: Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. Environ Health Perspect. 1999, 107: 273-278. 10.2307/3434593.PubMedCentralCrossRefPubMed Cheek AO, Kow K, Chen J, McLachlan JA: Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. Environ Health Perspect. 1999, 107: 273-278. 10.2307/3434593.PubMedCentralCrossRefPubMed
5.
go back to reference Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS: Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect. 2003, 111: 994-1006.PubMedCentralCrossRefPubMed Welshons WV, Thayer KA, Judy BM, Taylor JA, Curran EM, vom Saal FS: Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect. 2003, 111: 994-1006.PubMedCentralCrossRefPubMed
6.
go back to reference Kang JH, Kondo F, Katayama Y: Human exposure to bisphenol A. Toxicology. 2006, 226: 79-89. 10.1016/j.tox.2006.06.009.CrossRefPubMed Kang JH, Kondo F, Katayama Y: Human exposure to bisphenol A. Toxicology. 2006, 226: 79-89. 10.1016/j.tox.2006.06.009.CrossRefPubMed
7.
go back to reference Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV: Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007, 24: 139-177. 10.1016/j.reprotox.2007.07.010.CrossRefPubMed Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV: Human exposure to bisphenol A (BPA). Reprod Toxicol. 2007, 24: 139-177. 10.1016/j.reprotox.2007.07.010.CrossRefPubMed
8.
go back to reference Durando M, Kass L, Piva J, Sonnenschein C, Soto AM, Luque EH, Munoz-de-Toro M: Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect. 2007, 115: 80-86.PubMedCentralCrossRefPubMed Durando M, Kass L, Piva J, Sonnenschein C, Soto AM, Luque EH, Munoz-de-Toro M: Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect. 2007, 115: 80-86.PubMedCentralCrossRefPubMed
9.
go back to reference Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS: Exposure to bisphenol A advances puberty. Nature. 1999, 401: 763-764. 10.1038/44517.CrossRefPubMed Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS: Exposure to bisphenol A advances puberty. Nature. 1999, 401: 763-764. 10.1038/44517.CrossRefPubMed
10.
go back to reference Howdeshell KL, Wilson VS, Furr J, Lambright CR, Rider CV, Blystone CR, Hotchkiss AK, Gray LE: A mixture of five phthalate esters inhibits fetal testicular testosterone production in the sprague-dawley rat in a cumulative, dose-additive manner. Toxicol Sci. 2008, 105: 153-165. 10.1093/toxsci/kfn077.CrossRefPubMed Howdeshell KL, Wilson VS, Furr J, Lambright CR, Rider CV, Blystone CR, Hotchkiss AK, Gray LE: A mixture of five phthalate esters inhibits fetal testicular testosterone production in the sprague-dawley rat in a cumulative, dose-additive manner. Toxicol Sci. 2008, 105: 153-165. 10.1093/toxsci/kfn077.CrossRefPubMed
11.
go back to reference Kubo K, Arai O, Ogata R, Omura M, Hori T, Aou S: Exposure to bisphenol A during the fetal and suckling periods disrupts sexual differentiation of the locus coeruleus and of behavior in the rat. Neurosci Lett. 2001, 304: 73-76. 10.1016/S0304-3940(01)01760-8.CrossRefPubMed Kubo K, Arai O, Ogata R, Omura M, Hori T, Aou S: Exposure to bisphenol A during the fetal and suckling periods disrupts sexual differentiation of the locus coeruleus and of behavior in the rat. Neurosci Lett. 2001, 304: 73-76. 10.1016/S0304-3940(01)01760-8.CrossRefPubMed
12.
go back to reference Kubo K, Arai O, Omura M, Watanabe R, Ogata R, Aou S: Low dose effects of bisphenol A on sexual differentiation of the brain and behavior in rats. Neurosci Res. 2003, 45: 345-356. 10.1016/S0168-0102(02)00251-1.CrossRefPubMed Kubo K, Arai O, Omura M, Watanabe R, Ogata R, Aou S: Low dose effects of bisphenol A on sexual differentiation of the brain and behavior in rats. Neurosci Res. 2003, 45: 345-356. 10.1016/S0168-0102(02)00251-1.CrossRefPubMed
13.
go back to reference Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, Vandenbergh JG, Walser-Kuntz DR, vom Saal FS: In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol. 2007, 24: 199-224. 10.1016/j.reprotox.2007.06.004.PubMedCentralCrossRefPubMed Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, Vandenbergh JG, Walser-Kuntz DR, vom Saal FS: In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol. 2007, 24: 199-224. 10.1016/j.reprotox.2007.06.004.PubMedCentralCrossRefPubMed
14.
go back to reference Rubin BS, Lenkowski JR, Schaeberle CM, Vandenberg LN, Ronsheim PM, Soto AM: Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology. 2006, 147: 3681-3691. 10.1210/en.2006-0189.CrossRefPubMed Rubin BS, Lenkowski JR, Schaeberle CM, Vandenberg LN, Ronsheim PM, Soto AM: Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology. 2006, 147: 3681-3691. 10.1210/en.2006-0189.CrossRefPubMed
15.
go back to reference Schonfelder G, Flick B, Mayr E, Talsness C, Paul M, Chahoud I: In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vagina. Neoplasia. 2002, 4: 98-102. 10.1038/sj.neo.7900212.PubMedCentralCrossRefPubMed Schonfelder G, Flick B, Mayr E, Talsness C, Paul M, Chahoud I: In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vagina. Neoplasia. 2002, 4: 98-102. 10.1038/sj.neo.7900212.PubMedCentralCrossRefPubMed
16.
go back to reference Timms BG, Howdeshell KL, Barton L, Bradley S, Richter CA, vom Saal FS: Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA. 2005, 102: 7014-7019. 10.1073/pnas.0502544102.PubMedCentralCrossRefPubMed Timms BG, Howdeshell KL, Barton L, Bradley S, Richter CA, vom Saal FS: Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci USA. 2005, 102: 7014-7019. 10.1073/pnas.0502544102.PubMedCentralCrossRefPubMed
17.
go back to reference Terasaka H, Kadoma Y, Sakagami H, Fujisawa S: Cytotoxicity and apoptosis-inducing activity of bisphenol A and hydroquinone in HL-60 cells. Anticancer Res. 2005, 25: 2241-2247.PubMed Terasaka H, Kadoma Y, Sakagami H, Fujisawa S: Cytotoxicity and apoptosis-inducing activity of bisphenol A and hydroquinone in HL-60 cells. Anticancer Res. 2005, 25: 2241-2247.PubMed
18.
go back to reference Terasaka H, Morshed SR, Hashimoto K, Sakagami H, Fujisawa S: Hydroquinone-induced apoptosis in HL-60 cells. Anticancer Res. 2005, 25: 161-170.PubMed Terasaka H, Morshed SR, Hashimoto K, Sakagami H, Fujisawa S: Hydroquinone-induced apoptosis in HL-60 cells. Anticancer Res. 2005, 25: 161-170.PubMed
19.
go back to reference Scognamiglio A, Nebbioso A, Manzo F, Valente S, Mai A, Altucci L: HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2. Biochim Biophys Acta. 2008, 1783: 2030-2038. 10.1016/j.bbamcr.2008.07.007.CrossRefPubMed Scognamiglio A, Nebbioso A, Manzo F, Valente S, Mai A, Altucci L: HDAC-class II specific inhibition involves HDAC proteasome-dependent degradation mediated by RANBP2. Biochim Biophys Acta. 2008, 1783: 2030-2038. 10.1016/j.bbamcr.2008.07.007.CrossRefPubMed
20.
go back to reference Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H: Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med. 2001, 7: 680-686. 10.1038/89050.CrossRefPubMed Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H: Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med. 2001, 7: 680-686. 10.1038/89050.CrossRefPubMed
21.
go back to reference Nebbioso A, Clarke N, Voltz E, Germain E, Ambrosino C, Bontempo P, Alvarez R, Schiavone EM, Ferrara F, Bresciani F, Weisz A, de Lera AR, Gronemeyer H, Altucci L: Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. Nat Med. 2005, 11: 77-84. 10.1038/nm1161.CrossRefPubMed Nebbioso A, Clarke N, Voltz E, Germain E, Ambrosino C, Bontempo P, Alvarez R, Schiavone EM, Ferrara F, Bresciani F, Weisz A, de Lera AR, Gronemeyer H, Altucci L: Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. Nat Med. 2005, 11: 77-84. 10.1038/nm1161.CrossRefPubMed
22.
go back to reference Mai A, Valente S, Nebbioso A, Simeoni S, Ragno R, Massa S, Brosch G, De Bellis F, Manzo F, Altucci L: New pyrrole-based histone deacetylase inhibitors: Binding mode, enzyme- and cell-based investigations. Int J Biochem Cell Biol. 2009, 41: 235-247. 10.1016/j.biocel.2008.09.002.CrossRefPubMed Mai A, Valente S, Nebbioso A, Simeoni S, Ragno R, Massa S, Brosch G, De Bellis F, Manzo F, Altucci L: New pyrrole-based histone deacetylase inhibitors: Binding mode, enzyme- and cell-based investigations. Int J Biochem Cell Biol. 2009, 41: 235-247. 10.1016/j.biocel.2008.09.002.CrossRefPubMed
23.
go back to reference Mai A, Cheng D, Bedford MT, Valente S, Nebbioso A, Perrone A, Brosch G, Sbardella G, De Bellis F, Miceli M, Altucci L: epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors. J Med Chem. 2008, 51: 2279-2290. 10.1021/jm701595q.CrossRefPubMed Mai A, Cheng D, Bedford MT, Valente S, Nebbioso A, Perrone A, Brosch G, Sbardella G, De Bellis F, Miceli M, Altucci L: epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors. J Med Chem. 2008, 51: 2279-2290. 10.1021/jm701595q.CrossRefPubMed
Metadata
Title
Molecular analysis of the apoptotic effects of BPA in acute myeloid leukemia cells
Authors
Paola Bontempo
Luigi Mita
Antonella Doto
Marco Miceli
Angela Nebbioso
Ilaria Lepore
GianLuigi Franci
Roberta Menafra
Vincenzo Carafa
Mariarosaria Conte
Floriana De Bellis
Fabio Manzo
Vincenzo Di Cerbo
Rosaria Benedetti
Loredana D'Amato
Maria Marino
Alessandro Bolli
Giovanna Del Pozzo
Nadia Diano
Marianna Portaccio
Gustavo D Mita
Maria Teresa Vietri
Michele Cioffi
Ernesto Nola
Carmela Dell'Aversana
Vincenzo Sica
Anna Maria Molinari
Lucia Altucci
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2009
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-7-48

Other articles of this Issue 1/2009

Journal of Translational Medicine 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.